Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH staff changes

This article was originally published in The Gray Sheet

Executive Summary

Acting director for the Division of Cardiovascular and Respiratory Devices is Celia Witten, following the death of former DCRD director Thomas Callahan on Oct. 16. Witten's previous post as director of the Division of General and Rehabilitation Devices will be filled by DGRD Deputy Director Jim Dillard. Nancy Brogdon also will move to DCRD Nov. 8 as interim deputy director, a position that has been vacant since former Deputy Director Dan Spyker's departure in May. Brogdon currently serves as deputy director for the Division of Ophthalmic and ENT Devices

You may also be interested in...



ODE Adding Third Deputy Director; Feigal Outlines CDRH Ombudsman Role

The Center for Devices and Radiological Health's next Office of Device Evaluation Director will possess a medical degree, CDRH Director David Feigal said in a Nov. 9 interview with "The Gray Sheet."

COVID Mutants: Vaccine Changes Likely To Need Immunogenicity Studies, Not Big Efficacy Trials

US FDA considering approach that is similar to, but more stringent than, influenza strain changes, CBER Director Marks says. But how to know what variants need a limited study and which one need a big one will be an ongoing challenge, NIH's Graham notes. As FDA and sponsors gain more experience with tweaking the vaccines to account for new coronavirus variants and strains, the process may be expedited further.

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel